VANGUARD GROUP INC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 171 filers reported holding REGENXBIO INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$72,038,392
-17.0%
4,376,573
+0.8%
0.00%0.0%
Q2 2023$86,757,439
+6.3%
4,340,042
+0.5%
0.00%0.0%
Q1 2023$81,634,867
-15.8%
4,317,021
+1.0%
0.00%
-33.3%
Q4 2022$96,900,165
-14.1%
4,272,494
+0.1%
0.00%0.0%
Q3 2022$112,792,000
+7.4%
4,267,542
+0.4%
0.00%0.0%
Q2 2022$105,033,000
-22.3%
4,252,323
+4.5%
0.00%0.0%
Q1 2022$135,099,000
+1.9%
4,070,462
+0.4%
0.00%0.0%
Q4 2021$132,565,000
-21.1%
4,053,966
+1.1%
0.00%
-25.0%
Q3 2021$168,064,000
+9.7%
4,009,182
+1.7%
0.00%0.0%
Q2 2021$153,215,000
+14.1%
3,943,759
+0.2%
0.00%0.0%
Q1 2021$134,265,000
-11.3%
3,936,232
+18.0%
0.00%0.0%
Q4 2020$151,289,000
+69.3%
3,335,298
+2.7%
0.00%
+33.3%
Q3 2020$89,361,000
-29.7%
3,247,098
-5.9%
0.00%
-40.0%
Q2 2020$127,077,000
+10.7%
3,450,367
-2.7%
0.01%0.0%
Q1 2020$114,784,000
-18.1%
3,544,905
+3.6%
0.01%0.0%
Q4 2019$140,163,000
+23.4%
3,421,100
+7.2%
0.01%
+25.0%
Q3 2019$113,625,000
-35.9%
3,191,703
-7.5%
0.00%
-42.9%
Q2 2019$177,220,000
-9.2%
3,449,874
+1.3%
0.01%
-12.5%
Q1 2019$195,164,000
+37.3%
3,405,422
+0.5%
0.01%
+33.3%
Q4 2018$142,132,000
-32.9%
3,388,104
+20.7%
0.01%
-25.0%
Q3 2018$211,851,000
+58.9%
2,805,969
+51.0%
0.01%
+33.3%
Q2 2018$133,332,000
+247.7%
1,858,298
+44.7%
0.01%
+200.0%
Q1 2018$38,345,000
-5.7%
1,284,580
+5.1%
0.00%0.0%
Q4 2017$40,656,000
+1.7%
1,222,720
+0.8%
0.00%0.0%
Q3 2017$39,962,000
+86.9%
1,212,798
+12.0%
0.00%
+100.0%
Q2 2017$21,379,000
+12.9%
1,082,461
+10.3%
0.00%0.0%
Q1 2017$18,942,000
+28.2%
981,517
+23.2%
0.00%0.0%
Q4 2016$14,781,000
+37.7%
796,817
+4.0%
0.00%0.0%
Q3 2016$10,736,000
+135.5%
766,315
+34.5%
0.00%
Q2 2016$4,559,000
+60.3%
569,935
+116.4%
0.00%
Q1 2016$2,844,000
-15.7%
263,339
+29.5%
0.00%
Q4 2015$3,375,000
+411.4%
203,322
+578.5%
0.00%
Q3 2015$660,00029,9660.00%
Other shareholders
REGENXBIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 1,459,128$110,164,0006.60%
ArchPoint Investors 224,187$16,926,0004.60%
Redmile Group, LLC 1,656,065$125,033,0003.85%
WS MANAGEMENT LLLP 954,812$72,088,0002.37%
HIGHLINE CAPITAL MANAGEMENT, L.P. 342,000$25,821,0001.19%
Perceptive Advisors 470,672$35,536,0000.95%
Pier Capital, LLC 94,492$7,134,0000.90%
Ipswich Investment Management Co., Inc. 29,932$2,260,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 275,000$20,763,0000.74%
Timpani Capital Management LLC 27,835$2,102,0000.61%
View complete list of REGENXBIO INC shareholders